4//SEC Filing
Barlow Carrolee 4
Accession 0001104659-22-026878
CIK 0001356576other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:24 PM ET
Size
16.6 KB
Accession
0001104659-22-026878
Insider Transaction Report
Form 4
Barlow Carrolee
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-02-22+6,847→ 6,847 totalExercise: $32.20From: 2023-02-22Exp: 2032-02-22→ Common Stock (6,847 underlying) - Award
Restricted Stock Units
2022-02-22+3,882→ 3,882 total→ Common Stock (3,882 underlying)
Holdings
- 9,433
Common Stock
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F2]These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023.
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001745316
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 9:24 PM ET
- Size
- 16.6 KB